Skip to main content
NEXTURNBIOSCIENCE Co., LTD logo

NEXTURNBIOSCIENCE Co., LTD — Investor Relations & Filings

Ticker · 089140 ISIN · KR7089140008 KO Professional, scientific and technical activities
Open in API
Filings indexed 486 across all filing types
Latest filing 2024-01-23 Major Shareholding Noti…
Country KR South Korea
Listing KO 089140

About NEXTURNBIOSCIENCE Co., LTD

http://www.nexturn.co.kr

NEXTURNBIOSCIENCE Co., LTD. is a specialized manufacturer of Computer Numerical Control (CNC) automatic lathes, with a focus on Swiss-type models. The company develops and produces a range of machines, including both guide bush and non-guide bush types, utilizing proprietary technology. In addition to its core machinery business, NEXTURNBIOSCIENCE leverages its expertise in ultra-precision manufacturing to produce essential functional components. These high-quality parts serve critical applications across diverse sectors, including information technology (IT), construction equipment, and the medical industry, reflecting the company's expanding business scope.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, including convertible bonds and voting rights, by a major shareholder (Studio Santa Claus Entertainment) in a listed company (Nexturn Bioscience). This type of filing is specifically categorized as a Major Shareholding Notification (MRQ) in the provided schema.
2024-01-23 Korean
전환가액의조정
Capital/Financing Update Classification · 1% confidence The document is a formal regulatory filing from a Korean company (Nexturn Bio) regarding the adjustment of the conversion price of convertible bonds due to a decline in stock price. This type of disclosure is a standard capital structure update related to financing instruments. Among the provided categories, 'CAP' (Capital/Financing Update) is the most accurate classification for adjustments to convertible security terms.
2024-01-22 Korean
전환가액의조정
Share Issue/Capital Change Classification · 1% confidence The document is a formal regulatory filing from a Korean company (Nexturn Bio) regarding the adjustment of the conversion price of convertible bonds due to a decline in stock price. This type of disclosure is a standard corporate action related to capital structure and financing instruments. Among the provided categories, 'CAP' (Capital/Financing Update) is the most accurate fit as it covers updates on financing activities and capital structure changes, including adjustments to convertible securities.
2024-01-19 Korean
[기재정정]기타경영사항(자율공시)(제1,3,4회차 무기명식 무보증 사모 전환사채 만기전 취득 후 재매각의 건)
Capital/Financing Update Classification · 1% confidence The document is a regulatory filing from a Korean company (Nexturn Bio) regarding the 'acquisition before maturity and resale' of convertible bonds. It details changes to the terms of a previously announced transaction, including contract amendments, payment schedules, and the cancellation of a specific bond series (2nd series). This type of disclosure regarding financing activities, capital structure, and debt instruments falls under the 'Capital/Financing Update' category.
2024-01-19 Korean
주요사항보고서(소송등의제기)
Legal Proceedings Report Classification · 1% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean financial authorities regarding the filing of a lawsuit/legal appeal (소송 등의 제기). It details the parties involved in a legal dispute, the court, and the nature of the appeal. Since it specifically addresses legal proceedings and litigation, it falls under the 'Legal Proceedings Report' category.
2024-01-18 Korean
전환가액의조정
Capital/Financing Update Classification · 1% confidence The document is a formal regulatory filing from a Korean company (Nexturn Bio) regarding the adjustment of the conversion price of convertible bonds. This type of disclosure is a standard corporate action related to capital structure and financing instruments. Since it details the specific change in conversion price and the resulting impact on the number of convertible shares, it falls under the 'Capital/Financing Update' category.
2024-01-08 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.